Betterlife Pharma Surges 25% as Investors Anticipate New Clinical Milestones
Betterlife Pharma’s stock jumps 25% as investors spot fresh pipeline progress, highlighting its nutraceutical platform and potential for future upside.
3 minutes to read
BETTERLIFE PHARMA INC